A methionine-Mettl3-N 6-methyladenosine axis promotes polycystic kidney disease

Ramalingam H
UT Southwestern
April 1, 2021
Cell Metab
https://pubmed.ncbi.nlm.nih.gov/33852874

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/33852874

Research summary

METTL3 and m⁶A levels are elevated in mouse and human ADPKD samples. Kidney‑specific overexpression of Mettl3 induces tubular cysts; conditional deletion slows cyst growth in three orthologous ADPKD mouse models. Elevated methionine/SAM drive Mettl3 expression and cystogenesis; dietary methionine restriction attenuates disease. METTL3 increases m⁶A and translation of c‑Myc and Avpr2.

Key outcome of the study

Mettl3 overexpression promotes cystogenesis; KO delays cyst growth; methionine/SAM axis regulates METTL3; dietary restriction modulates disease; c‑Myc and Avpr2 regulated via m⁶A

Model

Mettl3^flox/flox conditional knockout mouse (genOway-developed) crossed with kidney-specific Cre drivers in ADPKD backgrounds

TARGET:
Mettl3
Synonyms:
Mettl3; Mettl‑3; MT‑A70‑like 3

Keywords

ADPKD; renal cystogenesis; RNA methylation; metabolic regulation; dietary therapy; c‑Myc, Avpr2 signaling

Technical specifications

Conditional KO with kidney-specific Cre; ADPKD background (e.g., Pkd1, Pkd2); dietary methionine modulation; m⁶A-seq; translatome analysis

Related products

Catalogue product

No items found.

Customized product

No items found.
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe